DK170347B1 - Molekylært koordinationscomplex, fremgangsmåde til fremstilling heraf, anvendelse af complexet i et præparat og præparat indeholdende complexet - Google Patents

Molekylært koordinationscomplex, fremgangsmåde til fremstilling heraf, anvendelse af complexet i et præparat og præparat indeholdende complexet Download PDF

Info

Publication number
DK170347B1
DK170347B1 DK527680A DK527680A DK170347B1 DK 170347 B1 DK170347 B1 DK 170347B1 DK 527680 A DK527680 A DK 527680A DK 527680 A DK527680 A DK 527680A DK 170347 B1 DK170347 B1 DK 170347B1
Authority
DK
Denmark
Prior art keywords
cellulose
polymer
alcohol
carbon atoms
complex
Prior art date
Application number
DK527680A
Other languages
Danish (da)
English (en)
Other versions
DK527680A (da
Inventor
Stewart Thomas Leslie
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of DK527680A publication Critical patent/DK527680A/da
Application granted granted Critical
Publication of DK170347B1 publication Critical patent/DK170347B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/05—Alcohols; Metal alcoholates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK527680A 1979-12-19 1980-12-10 Molekylært koordinationscomplex, fremgangsmåde til fremstilling heraf, anvendelse af complexet i et præparat og præparat indeholdende complexet DK170347B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IE248079 1979-12-19
IE248179 1979-12-19
IE248179 1979-12-19
IE2480/79A IE49324B1 (en) 1979-12-19 1979-12-19 Controlled release compositions

Publications (2)

Publication Number Publication Date
DK527680A DK527680A (da) 1981-08-05
DK170347B1 true DK170347B1 (da) 1995-08-07

Family

ID=26319271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK527680A DK170347B1 (da) 1979-12-19 1980-12-10 Molekylært koordinationscomplex, fremgangsmåde til fremstilling heraf, anvendelse af complexet i et præparat og præparat indeholdende complexet

Country Status (27)

Country Link
US (1) US4366310A (no)
EP (1) EP0032004B1 (no)
JP (1) JPS5698201A (no)
AU (1) AU541246B2 (no)
BE (1) BE886711A (no)
CA (1) CA1168230A (no)
CS (1) CS228142B2 (no)
DE (1) DE3048028A1 (no)
DK (1) DK170347B1 (no)
EG (1) EG14984A (no)
ES (1) ES8303489A1 (no)
FI (1) FI66623C (no)
FR (1) FR2474507B1 (no)
GB (1) GB2067569B (no)
GR (1) GR72265B (no)
HU (1) HU188085B (no)
IE (1) IE49324B1 (no)
IL (1) IL61677A (no)
MX (1) MX158088A (no)
NL (1) NL187401C (no)
NO (1) NO152846C (no)
NZ (1) NZ195793A (no)
PL (1) PL133079B1 (no)
PT (1) PT72214B (no)
SU (1) SU1178326A3 (no)
YU (1) YU40957B (no)
ZA (1) ZA807716B (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1211266A (en) * 1982-11-12 1986-09-16 Alfred E. Lauchenauer Shaped semi-solid articles
DE3306621A1 (de) * 1983-02-25 1984-08-30 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von celluloseethern mit einem dimethoxyethan enthaltenden dispergierhilfsmittel
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
EP0249347B1 (en) * 1986-06-10 1994-06-29 Euroceltique S.A. Controlled release dihydrocodeine composition
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US5079005A (en) * 1988-06-17 1992-01-07 Gupta Kashmiri L Time release protein
US5023080A (en) * 1988-06-17 1991-06-11 Basic Bio Systems, Inc. Time release protein
US5055300A (en) * 1988-06-17 1991-10-08 Basic Bio Systems, Inc. Time release protein
US5476668A (en) * 1990-08-24 1995-12-19 Shin-Etsu Chemical Co., Ltd. Base for film-coating pharmaceuticals and method for preparing same
IL109460A (en) 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
AU8532798A (en) * 1997-06-13 1998-12-30 Roland Bodmeier Compounds which delay the release of active substances
CA2314893C (en) 1997-12-22 2005-09-13 Euro-Celtique, S.A. Opioid agonist/antagonist combinations
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
BR0108379A (pt) 2000-02-08 2002-11-05 Euro Celtique Sa Composições de liberação controlada contendo agonista e antagonista opióide, método para a preparação de uma formulação em dosagem de analgésico opióide de liberação controlada com potência analgésica aumentada e sistema de administração através da derme para um analgésico opióide
DE60238756D1 (de) 2001-05-11 2011-02-10 Endo Pharmaceuticals Inc Opioid enthaltende arzneiform gegen missbrauch
AU2002316738B2 (en) 2001-07-18 2009-01-08 Euro-Celtique S.A. Pharmaceutical combinations of oxycodone and naloxone
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
WO2003013433A2 (en) 2001-08-06 2003-02-20 Euro-Celtique S.A. Sequestered antagonist formulations
HUP0401191A3 (en) 2001-08-06 2006-11-28 Euro Celtique Sa Opioid agonist formulations with releasable and sequestered antagonist and process for their preparation
EP1492506B2 (en) 2002-04-05 2016-06-29 Euro-Celtique S.A. Matrix for sustained, invariant and independent release of active compounds
SI1551372T1 (en) 2002-09-20 2018-08-31 Alpharma Pharmaceuticals Llc SUBVENCATION DATA AND RELATED CONSTRUCTIONS AND PROCEDURES
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
PT1765292T (pt) 2004-06-12 2017-12-29 Collegium Pharmaceutical Inc Formulações de fármacos dissuasoras de abuso
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
DK2526932T3 (en) 2006-06-19 2017-07-17 Alpharma Pharmaceuticals Llc Pharmaceutical composition
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
JP2010159364A (ja) * 2009-01-09 2010-07-22 Kyoto Univ セルロースの高温での着色を抑制する方法
MX347106B (es) 2009-03-10 2017-04-12 Euro-Celtique S A * Coposiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona.
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
EA201291211A1 (ru) 2010-05-10 2013-05-30 Эро-Селтик С.А. Фармацевтические композиции, содержащие гидроморфон и налоксон
US9901540B2 (en) 2010-05-10 2018-02-27 Euro-Celtique S.A. Combination of active loaded granules with additional actives
CN103002882B (zh) * 2010-05-10 2016-03-02 欧洲凯尔特公司 不含活性剂之颗粒及包含其之片剂的制备
CN103370058A (zh) 2010-12-22 2013-10-23 普渡制药公司 包覆的抗篡改控制释放剂型
CA2822769C (en) 2010-12-23 2016-10-04 Purdue Pharma L.P. Tamper resistant solid oral dosage forms
KR101840526B1 (ko) 2013-02-05 2018-03-20 퍼듀 퍼머 엘피 내변조성 제약 제제
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
CA2918004C (en) 2013-07-23 2018-11-20 Euro-Celtique S.A. A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
KR102194174B1 (ko) 2013-11-13 2020-12-23 유로-셀티큐 에스.에이. 통증 및 오피오이드 장 기능장애 증후군의 치료를 위한 히드로모르폰 및 날록손
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264766A (en) * 1877-09-19 1981-04-28 Hoffmann-La Roche Inc. Immunological diagnostic reagents
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
GB1405088A (en) * 1971-06-03 1975-09-03 Mundipharma Ag Slow release formulation
US3988482A (en) * 1971-08-27 1976-10-26 Toyo Hakka Kogyo Kabushiki Kaisha Menthol glycoside, process for preparing the same and method for releasing menthol therefrom
US3818107A (en) * 1972-09-28 1974-06-18 Brook D Chewing gum with sustained flavor release compositions
US3899439A (en) * 1973-03-12 1975-08-12 Hercules Inc Method of preparing aqueous dispersions of hydroxypropyl cellulose
DE2644678A1 (de) * 1976-10-02 1978-04-06 Dynamit Nobel Ag Verfahren zur herstellung funktionalisierter cellulosen
JPS54105223A (en) * 1977-12-29 1979-08-18 Yamanouchi Pharmaceut Co Ltd Coating agent for solid medicine
US4259355A (en) * 1979-03-05 1981-03-31 International Flavors & Fragrances Inc. Chewing gum containing flavor composition and flavor composition therefor
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals

Also Published As

Publication number Publication date
EP0032004A2 (en) 1981-07-15
GB2067569B (en) 1983-09-01
NL187401C (nl) 1991-09-16
NL8006891A (nl) 1981-07-16
DK527680A (da) 1981-08-05
GR72265B (no) 1983-10-10
AU541246B2 (en) 1985-01-03
ES497906A0 (es) 1983-02-01
US4366310A (en) 1982-12-28
EG14984A (en) 1986-06-30
FI803848L (fi) 1981-06-20
NL187401B (nl) 1991-04-16
CS228142B2 (en) 1984-05-14
IE49324B1 (en) 1985-09-18
NO152846C (no) 1985-11-27
IE792480L (en) 1981-06-19
CA1168230A (en) 1984-05-29
YU40957B (en) 1986-08-31
YU321080A (en) 1983-06-30
PT72214A (en) 1980-08-01
AU6529880A (en) 1981-06-25
IL61677A (en) 1984-10-31
FR2474507A1 (fr) 1981-07-31
FI66623B (fi) 1984-07-31
BE886711A (fr) 1981-06-17
PL133079B1 (en) 1985-05-31
EP0032004A3 (en) 1982-07-14
ES8303489A1 (es) 1983-02-01
NO803836L (no) 1981-06-22
JPS5698201A (en) 1981-08-07
SU1178326A3 (ru) 1985-09-07
FR2474507B1 (fr) 1986-12-26
HU188085B (en) 1986-03-28
HUT34891A (en) 1985-05-28
ZA807716B (en) 1981-12-30
FI66623C (fi) 1984-11-12
NO152846B (no) 1985-08-19
IL61677A0 (en) 1981-01-30
MX158088A (es) 1989-01-06
NZ195793A (en) 1982-09-14
EP0032004B1 (en) 1985-05-15
PL228573A1 (no) 1982-07-19
PT72214B (en) 1981-11-02
DE3048028A1 (de) 1981-09-10
JPH0225921B2 (no) 1990-06-06
GB2067569A (en) 1981-07-30

Similar Documents

Publication Publication Date Title
DK170347B1 (da) Molekylært koordinationscomplex, fremgangsmåde til fremstilling heraf, anvendelse af complexet i et præparat og præparat indeholdende complexet
Lenaerts et al. Controlled release of theophylline from cross-linked amylose tablets
US4254099A (en) Pharmaceutical tablet composition
CA1079638A (en) Coated granules of polyacrylic alkali metal salts and method of producing same
CN104434805B (zh) 一种替格瑞洛固体分散体及其制备方法
JP2022507562A (ja) Ｐａｒｐインヒビタを含む医薬組成物
Kaur et al. Formulation and evaluation of carbopol 940 based glibenclamide transdermal gel
EP2349218A1 (de) Verfahren zur herstellung oraler darreichungsformen mit kontrollierter freisetzung
Chen et al. Combined application of extrusion-spheronization and hot-melt coating technologies for improving moisture-proofing of herbal extracts
US3853988A (en) Sustained released pharmaceutical compositions
Gad et al. Design, formulation, and evaluation of Piroxicam niosomal gel
US4406883A (en) Controlled release suppositories consisting essentially of a linear polymer particularly, polyvinyl pyrrolidones
HU208495B (en) Process for producing retarde pharmaceutical compositions
Mukherjee et al. Studies on Span based Soy-bigels with HPMC
Kornblum Sustained‐action tablets prepared by employing a spray‐drying technique for granulation
CA1208556A (en) Process for time controlled release of active ingredients from active material containing pharmaceutical preparations
CN115887730A (zh) 适用于水胶体敷贴的微球及其制备方法以及复合蛋白缓释水胶体敷贴
JP2638156B2 (ja) 薬剤組成物
CN105878215A (zh) 一种稳定的孟鲁司特口腔速溶膜及其制备方法和用途
CN114129573B (zh) 一种稳定的包含炔雌醇和醋酸炔诺酮的药物组合物
Thakur et al. Formulation and evaluation of mouth dissolving film of felodipine
CN109276550A (zh) 一种左炔诺孕酮片及其制备方法
Suryawanshi et al. Hot Melt Extrusion Assisted Felodipine Loaded Liquid Crystal Precursor with Enhanced Solubility and Sustained Drug Release Characteristics
MXPA04011796A (es) Unidades de dosificacion progestagenica.
CN110448694A (zh) 一种含抗氧剂的苯磺酸左氨氯地平组合物及其制备方法和应用

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired